Tuesday, November 9, 2010

Pharmacy industrial Growth

Since drafting the State Biotech Policy in 2001, the sector has witnessed significant growth in terms of attaining critical mass and infrastructure development, which was a result of the perennial and combined efforts of the government, the industry and the academia in the State. The policy has provided -- single window clearance system, sales tax of one per cent, provision of rebate based on the employment opportunity created and capital subsidy of 25 per cent of the total project cost is offered to those companies that are setting up biotech related infrastructure in Genome Valley, the country's first biotechnology and pharmaceutical cluster has been one of the earliest initiatives of the state government. This cluster houses, a world class centre for leading edge business driven research and is India's first such venture created in collaboration between research community and industry. During the phase I, about 10 laboratories had been operational from June 2000. In the second phase, 100 per cent laboratory space has been booked by seven companies. In the phase III, about 20,000 sq. ft of modular wet laboratory space is being developed. A Life Sciences Incubation Centre has been set up in the park with an investment of Rs 3 crore with eight labs, of which four will be exclusively for biotech and the remaining labs will be for chemistry.Can you tell us about the international companies that have set up base in the Genome Valley? Many overseas companies have shown interest to set up base in and around Hyderabad. Few companies have already set up their base. For instance, Taros Custom Chemicals, Germany, involved in providing research services to pharma and biotech companies has established its R&D facility in focused on R & D, registration and sale of generic dossiers, contract manufacturing and packaging of human therapeutics and veterinary drugs is in the process of starting its operations soon at Hyderabad. NND Biomedical Data Systems and Albany Molecular Research, both from USA have evinced keen interest.

No comments:

Post a Comment